Using random testing to manage a safe exit from the COVID-19 lockdown
Markus M\"uller, Peter M. Derlet, Christopher Mudry, and Gabriel, Aeppli

TL;DR
Frequent random testing of a large population can effectively monitor and manage COVID-19 spread, enabling timely decisions on restrictions and potential safe exit strategies based on real-time infection data.
Contribution
This paper proposes a practical, data-driven approach using daily random testing to improve pandemic predictability and inform policy decisions, including safe relaxation of restrictions.
Findings
15000 tests per day suffice for reliable infection estimates
Higher testing capacity reveals geographic spread differences
Real-time sampling enables earlier safe relaxation of restrictions
Abstract
We argue that frequent sampling of the fraction of infected people (either by random testing or by analysis of sewage water), is central to managing the COVID-19 pandemic because it both measures in real time the key variable controlled by restrictive measures, and anticipates the load on the healthcare system due to progression of the disease. Knowledge of random testing outcomes will (i) significantly improve the predictability of the pandemic, (ii) allow informed and optimized decisions on how to modify restrictive measures, with much shorter delay times than the present ones, and (iii) enable the real-time assessment of the efficiency of new means to reduce transmission rates. Here we suggest, irrespective of the size of a suitably homogeneous population, a conservative estimate of 15000 for the number of randomly tested people per day which will suffice to obtain reliable data…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 epidemiological studies · SARS-CoV-2 detection and testing · SARS-CoV-2 and COVID-19 Research
